[Antidiabetic agents and renal insufficiency].
D000284:Administration, Oral; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003921:Diabetes Mellitus, Experimental / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy; D003928:Diabetic Nephropathies / Q000150:complications* / Q000188:drug therapy; D005921:Glomerulonephritis / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D006943:Hyperglycemia / Q000209:etiology / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000145:classification / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008658:Inactivation, Metabolic; D007328:Insulin / Q000627:therapeutic use; D007333:Insulin Resistance; D007668:Kidney / Q000187:drug effects / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000517:prevention & control*; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D012084:Renin-Angiotensin System / Q000187:drug effects; D013844:Thiazoles / Q000493:pharmacokinetics / Q000627:therapeutic use
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D013844:Thiazoles
Antidiabéticos e insuficiencia renal.